調査レポート | • レポートコード：QYR2104Z3680 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥553,800 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥830,700 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,107,600 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、黒色腫治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、免疫療法、標的療法）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・黒色腫治療薬の市場動向 ・企業の競争状況、市場シェア ・黒色腫治療薬の種類別市場規模（化学療法、免疫療法、標的療法） ・黒色腫治療薬の用途別市場規模（病院、クリニック、その他） ・黒色腫治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・黒色腫治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・黒色腫治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・黒色腫治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・黒色腫治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Amgen、Bristol-Myers Squibb、Roche、Genentech、Janssen Biotech、Novartis、Pfizer、Sanofi、Takeda Pharma、Teva Pharma） ・結論 |
Melanoma is the type of cancer, in which the normal melanin-producing cells called melanocytes are turned into cancerous cells. Melanoma is usually, but not always cancer of the skin and is the most dangerous type of cancer. Mutation in melanin-producing melanocytes leads to uncontrolled division of cells forming the malignant tumor. Mainly there are three general categories of melanoma as Cutaneous, mucosal and ocular. Cutaneous melanoma is melanoma of the skin and is most common because most pigment cells are found in the skin. Mucosal melanoma is melanoma of mucous membrane of the body, including the mouth, the nasal passages, the throat, the vagina or the anus. The rare ocular melanoma or uveal melanoma occurs in the eye.
Market Analysis and Insights: Global Melanoma Drugs Market
The global Melanoma Drugs market size is projected to reach US$ 4803.4 million by 2026, from US$ 2154.4 million in 2019, at a CAGR of 12.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Melanoma Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Melanoma Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Melanoma Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Melanoma Drugs market.
Global Melanoma Drugs Scope and Market Size
Melanoma Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Melanoma Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Chemotherapy
Immunotherapy
Targeted Therapy
Segment by Application
Hospitals
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Amgen
Bristol-Myers Squibb
Roche
Genentech
Janssen Biotech
Novartis
Pfizer
Sanofi
Takeda Pharma
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Melanoma Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Immunotherapy
1.2.4 Targeted Therapy
1.3 Market by Application
1.3.1 Global Melanoma Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Melanoma Drugs Market Perspective (2016-2027)
2.2 Melanoma Drugs Growth Trends by Regions
2.2.1 Melanoma Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Melanoma Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Melanoma Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Melanoma Drugs Industry Dynamic
2.3.1 Melanoma Drugs Market Trends
2.3.2 Melanoma Drugs Market Drivers
2.3.3 Melanoma Drugs Market Challenges
2.3.4 Melanoma Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Melanoma Drugs Players by Revenue
3.1.1 Global Top Melanoma Drugs Players by Revenue (2016-2021)
3.1.2 Global Melanoma Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Melanoma Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Melanoma Drugs Revenue
3.4 Global Melanoma Drugs Market Concentration Ratio
3.4.1 Global Melanoma Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Melanoma Drugs Revenue in 2020
3.5 Melanoma Drugs Key Players Head office and Area Served
3.6 Key Players Melanoma Drugs Product Solution and Service
3.7 Date of Enter into Melanoma Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Melanoma Drugs Breakdown Data by Type
4.1 Global Melanoma Drugs Historic Market Size by Type (2016-2021)
4.2 Global Melanoma Drugs Forecasted Market Size by Type (2022-2027)
5 Melanoma Drugs Breakdown Data by Application
5.1 Global Melanoma Drugs Historic Market Size by Application (2016-2021)
5.2 Global Melanoma Drugs Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Melanoma Drugs Market Size (2016-2027)
6.2 North America Melanoma Drugs Market Size by Type
6.2.1 North America Melanoma Drugs Market Size by Type (2016-2021)
6.2.2 North America Melanoma Drugs Market Size by Type (2022-2027)
6.2.3 North America Melanoma Drugs Market Size by Type (2016-2027)
6.3 North America Melanoma Drugs Market Size by Application
6.3.1 North America Melanoma Drugs Market Size by Application (2016-2021)
6.3.2 North America Melanoma Drugs Market Size by Application (2022-2027)
6.3.3 North America Melanoma Drugs Market Size by Application (2016-2027)
6.4 North America Melanoma Drugs Market Size by Country
6.4.1 North America Melanoma Drugs Market Size by Country (2016-2021)
6.4.2 North America Melanoma Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Melanoma Drugs Market Size (2016-2027)
7.2 Europe Melanoma Drugs Market Size by Type
7.2.1 Europe Melanoma Drugs Market Size by Type (2016-2021)
7.2.2 Europe Melanoma Drugs Market Size by Type (2022-2027)
7.2.3 Europe Melanoma Drugs Market Size by Type (2016-2027)
7.3 Europe Melanoma Drugs Market Size by Application
7.3.1 Europe Melanoma Drugs Market Size by Application (2016-2021)
7.3.2 Europe Melanoma Drugs Market Size by Application (2022-2027)
7.3.3 Europe Melanoma Drugs Market Size by Application (2016-2027)
7.4 Europe Melanoma Drugs Market Size by Country
7.4.1 Europe Melanoma Drugs Market Size by Country (2016-2021)
7.4.2 Europe Melanoma Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Melanoma Drugs Market Size (2016-2027)
8.2 Asia-Pacific Melanoma Drugs Market Size by Type
8.2.1 Asia-Pacific Melanoma Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Melanoma Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Melanoma Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Melanoma Drugs Market Size by Application
8.3.1 Asia-Pacific Melanoma Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Melanoma Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Melanoma Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Melanoma Drugs Market Size by Region
8.4.1 Asia-Pacific Melanoma Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Melanoma Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Melanoma Drugs Market Size (2016-2027)
9.2 Latin America Melanoma Drugs Market Size by Type
9.2.1 Latin America Melanoma Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Melanoma Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Melanoma Drugs Market Size by Type (2016-2027)
9.3 Latin America Melanoma Drugs Market Size by Application
9.3.1 Latin America Melanoma Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Melanoma Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Melanoma Drugs Market Size by Application (2016-2027)
9.4 Latin America Melanoma Drugs Market Size by Country
9.4.1 Latin America Melanoma Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Melanoma Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Melanoma Drugs Market Size (2016-2027)
10.2 Middle East & Africa Melanoma Drugs Market Size by Type
10.2.1 Middle East & Africa Melanoma Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Melanoma Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Melanoma Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Melanoma Drugs Market Size by Application
10.3.1 Middle East & Africa Melanoma Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Melanoma Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Melanoma Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Melanoma Drugs Market Size by Country
10.4.1 Middle East & Africa Melanoma Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Melanoma Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Melanoma Drugs Introduction
11.1.4 Amgen Revenue in Melanoma Drugs Business (2016-2021)
11.1.5 Amgen Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Melanoma Drugs Introduction
11.2.4 Bristol-Myers Squibb Revenue in Melanoma Drugs Business (2016-2021)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Melanoma Drugs Introduction
11.3.4 Roche Revenue in Melanoma Drugs Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Genentech
11.4.1 Genentech Company Details
11.4.2 Genentech Business Overview
11.4.3 Genentech Melanoma Drugs Introduction
11.4.4 Genentech Revenue in Melanoma Drugs Business (2016-2021)
11.4.5 Genentech Recent Development
11.5 Janssen Biotech
11.5.1 Janssen Biotech Company Details
11.5.2 Janssen Biotech Business Overview
11.5.3 Janssen Biotech Melanoma Drugs Introduction
11.5.4 Janssen Biotech Revenue in Melanoma Drugs Business (2016-2021)
11.5.5 Janssen Biotech Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Melanoma Drugs Introduction
11.6.4 Novartis Revenue in Melanoma Drugs Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Melanoma Drugs Introduction
11.7.4 Pfizer Revenue in Melanoma Drugs Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Melanoma Drugs Introduction
11.8.4 Sanofi Revenue in Melanoma Drugs Business (2016-2021)
11.8.5 Sanofi Recent Development
11.9 Takeda Pharma
11.9.1 Takeda Pharma Company Details
11.9.2 Takeda Pharma Business Overview
11.9.3 Takeda Pharma Melanoma Drugs Introduction
11.9.4 Takeda Pharma Revenue in Melanoma Drugs Business (2016-2021)
11.9.5 Takeda Pharma Recent Development
11.10 Teva Pharma
11.10.1 Teva Pharma Company Details
11.10.2 Teva Pharma Business Overview
11.10.3 Teva Pharma Melanoma Drugs Introduction
11.10.4 Teva Pharma Revenue in Melanoma Drugs Business (2016-2021)
11.10.5 Teva Pharma Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Melanoma Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Immunotherapy
Table 4. Key Players of Targeted Therapy
Table 5. Global Melanoma Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Melanoma Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Melanoma Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Melanoma Drugs Market Share by Regions (2016-2021)
Table 9. Global Melanoma Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Melanoma Drugs Market Share by Regions (2022-2027)
Table 11. Melanoma Drugs Market Trends
Table 12. Melanoma Drugs Market Drivers
Table 13. Melanoma Drugs Market Challenges
Table 14. Melanoma Drugs Market Restraints
Table 15. Global Melanoma Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Melanoma Drugs Market Share by Players (2016-2021)
Table 17. Global Top Melanoma Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Melanoma Drugs as of 2020)
Table 18. Ranking of Global Top Melanoma Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Melanoma Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Melanoma Drugs Product Solution and Service
Table 22. Date of Enter into Melanoma Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Melanoma Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Melanoma Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Melanoma Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Melanoma Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Melanoma Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Melanoma Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Melanoma Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Melanoma Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Melanoma Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Melanoma Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Melanoma Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Melanoma Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Melanoma Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Melanoma Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Melanoma Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Melanoma Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Melanoma Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Melanoma Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Melanoma Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Melanoma Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Melanoma Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Melanoma Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Melanoma Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Melanoma Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Melanoma Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Melanoma Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Melanoma Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Melanoma Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Melanoma Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Melanoma Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Melanoma Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Melanoma Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Melanoma Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Melanoma Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Melanoma Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Melanoma Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Melanoma Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Melanoma Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Amgen Company Details
Table 63. Amgen Business Overview
Table 64. Amgen Melanoma Drugs Product
Table 65. Amgen Revenue in Melanoma Drugs Business (2016-2021) & (US$ Million)
Table 66. Amgen Recent Development
Table 67. Bristol-Myers Squibb Company Details
Table 68. Bristol-Myers Squibb Business Overview
Table 69. Bristol-Myers Squibb Melanoma Drugs Product
Table 70. Bristol-Myers Squibb Revenue in Melanoma Drugs Business (2016-2021) & (US$ Million)
Table 71. Bristol-Myers Squibb Recent Development
Table 72. Roche Company Details
Table 73. Roche Business Overview
Table 74. Roche Melanoma Drugs Product
Table 75. Roche Revenue in Melanoma Drugs Business (2016-2021) & (US$ Million)
Table 76. Roche Recent Development
Table 77. Genentech Company Details
Table 78. Genentech Business Overview
Table 79. Genentech Melanoma Drugs Product
Table 80. Genentech Revenue in Melanoma Drugs Business (2016-2021) & (US$ Million)
Table 81. Genentech Recent Development
Table 82. Janssen Biotech Company Details
Table 83. Janssen Biotech Business Overview
Table 84. Janssen Biotech Melanoma Drugs Product
Table 85. Janssen Biotech Revenue in Melanoma Drugs Business (2016-2021) & (US$ Million)
Table 86. Janssen Biotech Recent Development
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Melanoma Drugs Product
Table 90. Novartis Revenue in Melanoma Drugs Business (2016-2021) & (US$ Million)
Table 91. Novartis Recent Development
Table 92. Pfizer Company Details
Table 93. Pfizer Business Overview
Table 94. Pfizer Melanoma Drugs Product
Table 95. Pfizer Revenue in Melanoma Drugs Business (2016-2021) & (US$ Million)
Table 96. Pfizer Recent Development
Table 97. Sanofi Company Details
Table 98. Sanofi Business Overview
Table 99. Sanofi Revenue in Melanoma Drugs Business (2016-2021) & (US$ Million)
Table 100. Sanofi Recent Development
Table 101. Takeda Pharma Company Details
Table 102. Takeda Pharma Business Overview
Table 103. Takeda Pharma Melanoma Drugs Product
Table 104. Takeda Pharma Revenue in Melanoma Drugs Business (2016-2021) & (US$ Million)
Table 105. Takeda Pharma Recent Development
Table 106. Teva Pharma Company Details
Table 107. Teva Pharma Business Overview
Table 108. Teva Pharma Melanoma Drugs Product
Table 109. Teva Pharma Revenue in Melanoma Drugs Business (2016-2021) & (US$ Million)
Table 110. Teva Pharma Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Melanoma Drugs Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Immunotherapy Features
Figure 4. Targeted Therapy Features
Figure 5. Global Melanoma Drugs Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Melanoma Drugs Report Years Considered
Figure 10. Global Melanoma Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Melanoma Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Melanoma Drugs Market Share by Regions: 2020 VS 2027
Figure 13. Global Melanoma Drugs Market Share by Regions (2022-2027)
Figure 14. Global Melanoma Drugs Market Share by Players in 2020
Figure 15. Global Top Melanoma Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Melanoma Drugs as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Melanoma Drugs Revenue in 2020
Figure 17. Global Melanoma Drugs Revenue Market Share by Type (2016-2021)
Figure 18. Global Melanoma Drugs Revenue Market Share by Type (2022-2027)
Figure 19. North America Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Melanoma Drugs Market Share by Type (2016-2027)
Figure 21. North America Melanoma Drugs Market Share by Application (2016-2027)
Figure 22. North America Melanoma Drugs Market Share by Country (2016-2027)
Figure 23. United States Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Melanoma Drugs Market Share by Type (2016-2027)
Figure 27. Europe Melanoma Drugs Market Share by Application (2016-2027)
Figure 28. Europe Melanoma Drugs Market Share by Country (2016-2027)
Figure 29. Germany Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Melanoma Drugs Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Melanoma Drugs Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Melanoma Drugs Market Share by Region (2016-2027)
Figure 39. China Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Melanoma Drugs Market Share by Type (2016-2027)
Figure 47. Latin America Melanoma Drugs Market Share by Application (2016-2027)
Figure 48. Latin America Melanoma Drugs Market Share by Country (2016-2027)
Figure 49. Mexico Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Melanoma Drugs Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Melanoma Drugs Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Melanoma Drugs Market Share by Country (2016-2027)
Figure 55. Turkey Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Melanoma Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Amgen Revenue Growth Rate in Melanoma Drugs Business (2016-2021)
Figure 59. Bristol-Myers Squibb Revenue Growth Rate in Melanoma Drugs Business (2016-2021)
Figure 60. Roche Revenue Growth Rate in Melanoma Drugs Business (2016-2021)
Figure 61. Genentech Revenue Growth Rate in Melanoma Drugs Business (2016-2021)
Figure 62. Janssen Biotech Revenue Growth Rate in Melanoma Drugs Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Melanoma Drugs Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in Melanoma Drugs Business (2016-2021)
Figure 65. Sanofi Revenue Growth Rate in Melanoma Drugs Business (2016-2021)
Figure 66. Takeda Pharma Revenue Growth Rate in Melanoma Drugs Business (2016-2021)
Figure 67. Teva Pharma Revenue Growth Rate in Melanoma Drugs Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
世界の悪性黒色腫治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Malignant Melanoma Drugs Market The global Malignant Melanoma Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the …- 世界の黒色腫治療薬市場 2021：企業別、地域別、種類・用途別 The Melanoma Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, rec…
- 世界の黒色腫市場規模・現状・予測（2021年-2027年） Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are mo…
- 世界の黒色腫市場規模・現状・予測（2021年-2027年） Melanoma, also known as malignant melanoma, is a type of cancer that develops from the pigment-containing cells known as melanocytes. Melanomas typically occur in the skin, but may rarely occur in the mouth, intestines, or eye. In women, they most commonly occur on the legs, while in men they are mo…
- 世界の末端黒子型黒色腫治療市場規模・現状・予測（2021年-2027年） Acral Lentiginous Melanoma Drugs, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an analog of the human interleukin-2 gene. Market Analysis and Insights: Global Acral Lentiginous Melanoma Treatment Market The global Acral Lentiginous …